The only CTD dossier market intelligence and sourcing platform

Connect directly with CTD dossier owners and CDMOs without a brokerage fees

  • 82.500+

    CTD dossiers

  • 15.000+

    EU and US CTD dossiers

  • 2.000+

    Dossier owners and CDMO’s

  • 90% +

    Reply rate

  • Unlock access to detailed market data and insights on CTD dossiers in your desired product or therapeutic areas.
  • Explore information on pharmacopeia, dossier types (US, EU CTD), development status, country of origin, and more.
  • Stay ahead of the competition by forecasting the launch of competitive CTD dossiers across major markets, including the U.S. and Europe.

A Smart Way to Strengthen Your Portfolio

Optimize Your Strategic Investments

Enhance your portfolio with confidence by evaluating the competitive landscape of each target product and its dossier status. Make informed strategic decisions that align with your business development goals, ensuring a robust and competitive portfolio.

Leverage our SMART industry-specific search engine and filters to efficiently identify potential sources for your target products. Connect directly and confidentially with CTD dossier owners and manufacturers, with the ability to establish connections within 1-15 business days, all with just a few clicks.

Save Time and Reduce Sourcing Costs

Boost Your Profitability

Compare commercial terms offered by Pipelinepharma CTD dossier owners and manufacturers against your traditional sourcing channels. This allows you to select the most favorable terms, ensuring your company maximizes profitability on every deal.

What do our happy customers say about us?

Stephen Cuthbertson

Andreas Gerold

General Manager of Stragen Pharma GmbH

“The Pipelinepharma platform is incredibly easy to use, much like leading tech products. It lets us quickly assess the market by providing detailed information on commercially available CTD dossiers and finished formulations for our markets. Plus, it ensures direct, quick contact with dossier owners and manufacturers, acting as a personal assistant for our business development needs.”

Alona Pleshko

Alona Pleshko

New Projects Development Manager, JSC Kyiv Vitamin Plant

"Using Pipelinepharma’s Subscription plan has greatly benefited our portfolio expansion. We’ve made significant progress in securing contracts with several suppliers introduced to us, expanding our conversations beyond just one product. The user-friendly database and the supportive Pipelinepharma team enhance the experience, making it highly recommended."

Stephen Cuthbertson

Stephen Cuthbertson

CEO of Costapharm

“Pipelinepharma’s responsive and user-friendly platform has greatly streamlined our product sourcing process and facilitated valuable supplier connections. We are currently in active discussions with several suppliers and have already established commercial relationships with two companies, with three more agreements nearing finalization. This clearly demonstrates the platform’s effectiveness in linking us with viable suppliers. Their excellent customer service and efficient search function make the entire process easy and effective. We are thrilled with the results and the new business opportunities that have arisen. We look forward to continuing our partnership with Pipelinepharma, as they have become an essential part of our product sourcing strategy.”

Daniel Jesus Dagnino

Daniel Jesus Dagnino

Biosistemas (Grupo Medico Castro Diaz SC)

“Our partnership with Pipelinepharma resulted in remarkable success. In less than three months, we formalised a contract with a presented manufacturer for four products and started receiving shipments promptly. Continued discussions with other introduced manufacturers indicate further promising collaborations. Highly recommend Subscription plan service for efficient sourcing.”

Do you still have questions?

Trusted by

Tuple
Mirage
StaticKit
Transistor
Workcation
Workcation
And 10 000+ other companies

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible